66 related articles for article (PubMed ID: 26975700)
1. What is the predictive value of RECIST criteria following stereotactic lung radiation?
Gulstene S; Lang P; Melody Qu X; Laba JM; Yaremko BP; Rodrigues GB; Yu E; Qiabi M; Nayak R; Malthaner RA; Fortin D; Warner A; Inculet RI; Palma DA
Radiother Oncol; 2024 Jan; 190():109976. PubMed ID: 37918636
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Intra-thoracic Anatomical Changes upon the Delivery of Lung Stereotactic Ablative Radiotherapy.
Brown S; Beasley M; Aznar MC; Belderbos J; Chuter R; Cobben D; Faivre-Finn C; Franks K; Henry A; Murray L; Price G; van Herk M
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):e413-e421. PubMed ID: 34001380
[TBL] [Abstract][Full Text] [Related]
3. First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
Kamtam DN; Binkley MS; Kapula N; Sadeghi C; Nesbit S; Guo HH; Chang J; Maxim PG; Diehn M; Loo BW; Shrager JB
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38615887
[TBL] [Abstract][Full Text] [Related]
4. UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy.
Diez P; Hanna GG; Aitken KL; van As N; Carver A; Colaco RJ; Conibear J; Dunne EM; Eaton DJ; Franks KN; Good JS; Harrow S; Hatfield P; Hawkins MA; Jain S; McDonald F; Patel R; Rackley T; Sanghera P; Tree A; Murray L
Clin Oncol (R Coll Radiol); 2022 May; 34(5):288-300. PubMed ID: 35272913
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma.
Schep DG; Vansantvoort J; Dayes I; Lukka H; Quan K; Kapoor A; Chow T; Chu W; Swaminath A
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):832-837. PubMed ID: 38092258
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic ablative radiotherapy and FAPα-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer.
Chen M; Xiao L; Jia H; Wang S; Jiang X; Lei X; Zhai Q; Lang J
Radiother Oncol; 2023 Dec; 189():109946. PubMed ID: 37806560
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2- Breast Cancer Treated With Preoperative Stereotactic Ablative Body Radiotherapy.
Weinfurtner RJ; Abdalah M; Stringfield O; Ataya D; Williams A; Mooney B; Rosa M; Lee MC; Khakpour N; Laronga C; Czerniecki B; Diaz R; Ahmed K; Washington I; Latifi K; Niell BL; Montejo M; Raghunand N
J Breast Imaging; 2022; 4(3):273-284. PubMed ID: 36686407
[TBL] [Abstract][Full Text] [Related]
8. New techniques for assessing response after hypofractionated radiotherapy for lung cancer.
Mattonen SA; Huang K; Ward AD; Senan S; Palma DA
J Thorac Dis; 2014 Apr; 6(4):375-86. PubMed ID: 24688782
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence-assisted quantitative CT analysis of airway changes following SABR for central lung tumors.
Tekatli H; Bohoudi O; Hardcastle N; Palacios MA; Schneiders FL; Bruynzeel AME; Siva S; Senan S
Radiother Oncol; 2024 Jun; 198():110376. PubMed ID: 38857700
[TBL] [Abstract][Full Text] [Related]
10. Restricted bowel loop contouring: Improving efficiency in radiotherapy contouring for abdomino-pelvic Stereotactic Ablative Radiotherapy (SABR).
Clarke E; Howells R; Beasley M; Murray L
Clin Transl Radiat Oncol; 2020 Sep; 24():60-64. PubMed ID: 32637661
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Stereotactic Ablative Radiotherapy - a Multidisciplinary Approach.
Ahmad S
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):421-425. PubMed ID: 37179215
[No Abstract] [Full Text] [Related]
12. Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?
Loo BW
J Thorac Dis; 2011 Sep; 3(3):150-2. PubMed ID: 22263081
[No Abstract] [Full Text] [Related]
13. Risk for surgical complications after previous stereotactic body radiotherapy of the spine.
Roesch J; Cho JBC; Fahim DK; Gerszten PC; Flickinger JC; Grills IS; Jawad M; Kersh R; Letourneau D; Mantel F; Sahgal A; Shin JH; Winey B; Guckenberger M
Radiat Oncol; 2017 Sep; 12(1):153. PubMed ID: 28893299
[TBL] [Abstract][Full Text] [Related]
14. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.
Binkley MS; Shrager JB; Chaudhuri A; Popat R; Maxim PG; Shultz DB; Diehn M; Loo BW
Radiat Oncol; 2016 Mar; 11():40. PubMed ID: 26975700
[TBL] [Abstract][Full Text] [Related]
15. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
Binkley MS; Shrager JB; Leung AN; Popat R; Trakul N; Atwood TF; Chaudhuri A; Maxim PG; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):216-23. PubMed ID: 25015205
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.
Binkley MS; King MT; Shrager JB; Bush K; Chaudhuri AA; Popat R; Gensheimer MF; Maxim PG; Henry Guo H; Diehn M; Nair VS; Loo BW
Radiother Oncol; 2017 May; 123(2):270-275. PubMed ID: 28460826
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
Mirimanoff RO
Chin Clin Oncol; 2015 Dec; 4(4):42. PubMed ID: 26730754
[TBL] [Abstract][Full Text] [Related]
19. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature.
Huang K; Dahele M; Senan S; Guckenberger M; Rodrigues GB; Ward A; Boldt RG; Palma DA
Radiother Oncol; 2012 Mar; 102(3):335-42. PubMed ID: 22305958
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
